Payment completion for new share issuance as part of restricted stock. Number of issued shares: 14,200 shares; issue price: 383 yen; total amount: 5,438,600 yen. Allotments: two directors and two executive officers.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4492","jir_company_name":"Genetech Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-18","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4492-20260918-01.pdf","jir_short_summary":"Payment completion for new share issuance as part of restricted stock. Number of issued shares: 14,200 shares; issue price: 383 yen; total amount: 5,438,600 yen. Allotments: two directors and two executive officers.","jir_summary":"### Section Heading\nThis notice communicates the completion of payment for a new share issuance as restricted stock compensation. The issued ordinary shares amount to 14,200 shares at 383 yen per share, totaling 5,438,600 yen. Allotments are set for two directors (excluding directors who are Audit & Supervisory Board members and outside directors) and two executive officers who do not concurrently serve as directors. No additional information is provided regarding the relevant matters.\n\n### Section 2 Heading\nThe new share issuance this time was executed as part of stock compensation and does not involve direct capital increases or market financing as part of capital policy. It is important that the payment completion date is September 18, 2026. Further disclosures are expected regarding potential dilution effects and the long-term impact of the compensation design.","jir_financial_highlights":"Total issued shares: 14,200 shares (Unknown)\nIssue price: 383 yen (Unknown)\nTotal issue amount: 5,438,600 yen (Unknown)\nAllotments: Two directors \/ two executive officers (Unknown)","jir_category":"","jir_hashtags":"#Genetech, #Stock Compensation, #New Share Issuance","jir_key_figures":"Total issued shares: 14,200 shares\nIssue price: 383 yen\nTotal issue amount: 5,438,600 yen","jir_meta_title":"Genetech Co., Ltd. - Payment Completion for New Share Issuance under Restricted Stock | September 2026","jir_meta_description":"Notification of payment completion for new share issuance under restricted stock compensation. Shares issued: 14,200; issue price: 383 yen; total amount: 5,438,600 yen. Allotments: two directors and two executive officers.","jir_og_title":"Payment Completion for New Share Issuance under Restricted Stock Compensation","jir_og_description":"Disclosure of payment completion for new share issuance under restricted stock compensation. Overview of share count, amount, and allotments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59859,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-115090","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n